---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-070723"
form_type: "8-K"
ticker: "IFF"
cik: "0000051253"
company_name: "INTERNATIONAL FLAVORS & FRAGRANCES INC"
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T14:09:19.550625+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# IFF sells Pharma Solutions to Roquette for $2.85B enterprise value

## Summary
- Enterprise value up to $2.85B; EV/EBITDA multiple of ~13x.
- Pharma Solutions generated ~$1B revenue in 2023 with ~1,100 employees across 10 sites.
- Transaction expected to close first half 2025, subject to regulatory approvals.
- Sale supports IFF's debt leverage reduction target of 3.0x or below; portfolio optimization.
- CEO Erik Fyrwald says sale enables focus on core long-term profitable growth drivers.

## SEC filing metadata
- accession: 0001193125-24-070723
- form_type: 8-K
- ticker: IFF
- cik: 0000051253
- company_name: INTERNATIONAL FLAVORS & FRAGRANCES INC
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/51253/000119312524070723/0001193125-24-070723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/51253/000119312524070723/d762016d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-070723
- JSON: https://secwatch.observer/filing/0001193125-24-070723.json
- Plain text: https://secwatch.observer/filing/0001193125-24-070723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.